JAGX

Jaguar Health, Inc. JAGX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode JAGX GRI CNSP BDRX SILO INM GNPX SXTP CLDI CANF
6M -58.31 % -73.70 % -27.61 % -64.67 % -35.37 % -46.73 % -83.41 % -64.86 % -61.11 % -77.25 %
YTD -95.87 % -97.62 % -90.61 % -92.05 % -58.95 % -72.81 % -95.78 % -88.47 % -90.61 % -86.65 %
1Y -95.39 % -97.31 % -89.92 % -91.49 % -55.85 % -72.12 % -95.93 % -86.97 % -92.14 % -83.64 %
3Y -99.97 % -100.00 % -99.99 % -99.99 % -87.00 % -95.06 % -99.91 % -99.73 % -99.89 % -96.27 %
5Y -100.00 % -100.00 % -100.00 % -100.00 % 11.43 % -99.92 % -99.98 % -99.73 % -99.89 % -98.70 %
10Y -100.00 % -100.00 % -100.00 % -100.00 % 11.43 % -99.93 % -99.98 % -99.73 % -99.89 % -99.95 %
From the beginning -100.00 % -100.00 % -100.00 % -100.00 % 11.43 % -99.97 % -99.98 % -99.73 % -99.89 % -99.97 %

Dividend